China PharmaHub Corp. - FORM 10-K - EX-32.1 - CEO AND CFO CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002* - April 15, 2011

Attached files

file filename
10-K - CHINA PHARMAHUB 10K 12-31-2010 - China PharmaHub Corp.chinapharmahub_10k-122110.htm
EX-31.1 - CEO CERTIFICATION PURSUANT TO RULE 13A-14(A) (17 CFR 240.13A-14(A)) (17 CFR 240.13A-14(A)) OR RULE 15D-1(A) (17 CFR 240.15D-14(A))* - China PharmaHub Corp.exhibit_31-1.htm
EX-31.2 - CFO CERTIFICATION PURSUANT TO RULE 13A-14(A) (17 CFR 240.13A-14(A)) (17 CFR 240.13A-14(A)) OR RULE 15D-1(A) (17 CFR 240.15D-14(A))* - China PharmaHub Corp.exhibit_31-2.htm
EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Annual Report on Form 10-K for the Year Ended December 31, 2010 (the "Report") by China PharmaHub Corp. ("Registrant"), the undersigned hereby certifies that:

1.
to the  best of my knowledge, the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.
to the best of my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Registrant.

     
       
April 15, 2011 
By:
/s/ Richard Lui  
   
Richard Lui
  
   
President, Chief Executive Officer
  
       

Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Annual Report on Form 10-K for the Year Ended December 31, 2010 (the "Report") by China PharmaHub Corp. ("Registrant"), the undersigned hereby certifies that:

1.
to the  best of my knowledge, the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.
to the best of my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Registrant.

     
       
April 15, 2011    
By:
/s/ Monica Ding  
   
Monica Ding
  
   
Chief Financial Officer
  
       

China PharmaHub Corp. Reports